Expanding Treatment Horizons: FDA Approval of Tyenne®
Tanu Goyal
May 5, 2024
The US FDA approval of Fresenius Kabi’s Tyenne®, the first Tocilizumab biosimilar with both intravenous and subcutaneous formulations, is a breakthrough in bringing high-quality, affordable,
